G0S2 and chronic myelogenous leukemia, BCR-ABL1 positive: In CML patients, G0S2 expression was decreased in the CD34+ stem/progenitor cell compartment in blast phase CML (n = 5) compared to chronic phase patients (n = 6) [92].